Blockchain Registration Transaction Record

GeoVax Highlights Need for Domestic Vaccine Manufacturing Amid Global Outbreaks

GeoVax stresses importance of scalable U.S.-based vaccine manufacturing amid WHO Ebola emergency and mpox spread. GEO-MVA mpox/smallpox vaccine advances with Phase 3 trial planned for 2026.

GeoVax Highlights Need for Domestic Vaccine Manufacturing Amid Global Outbreaks

This news matters because it underscores the fragility of global vaccine supply chains and the critical need for diversified, scalable domestic manufacturing to respond swiftly to emerging infectious disease threats. As the WHO declares emergencies for Ebola and mpox, the advancement of GEO-MVA and similar platforms could be pivotal in ensuring long-term biodefense readiness and protecting public health against future pandemics.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x7ed9ba3e8e4a23de78a2a5d9cba57470d7b9822bcc0daeb63575146fac9c94d7
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintblurhax7-3182790540b348dcfe221d2915ff8943